prikaz prve stranice dokumenta The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015
  Preuzmi
PDF 899.7 KB
Znanstveni rad - Izvorni znanstveni rad
The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015
Expert Review of Pharmacoeconomics & Outcomes Research, 18 (2018), 6; 641-646. https://doi.org/10.1080/14737167.2018.1507820
Potočnjak, Ines; Likić, Robert; Degoricija, Vesna; Nham, Eric; Wettermark, Björn

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Potočnjak, I., Likić, R., Degoricija, V., Nham, E. i Wettermark, B. (2018). The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015. Expert Review of Pharmacoeconomics & Outcomes Research, 18. (6), 641-646. doi: 10.1080/14737167.2018.1507820

Potočnjak, Ines, et al. "The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015." Expert Review of Pharmacoeconomics & Outcomes Research, vol. 18, br. 6, 2018, str. 641-646. https://doi.org/10.1080/14737167.2018.1507820

Potočnjak, Ines, Robert Likić, Vesna Degoricija, Eric Nham i Björn Wettermark. "The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015." Expert Review of Pharmacoeconomics & Outcomes Research 18, br. 6 (2018): 641-646. https://doi.org/10.1080/14737167.2018.1507820

Potočnjak, I., et al. (2018) 'The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015', Expert Review of Pharmacoeconomics & Outcomes Research, 18(6), str. 641-646. doi: 10.1080/14737167.2018.1507820

Potočnjak I, Likić R, Degoricija V, Nham E, Wettermark B. The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015. Expert Review of Pharmacoeconomics & Outcomes Research [Internet]. 12.2018. [pristupljeno 24.12.2024.];18(6):641-646. doi: 10.1080/14737167.2018.1507820

I. Potočnjak, R. Likić, V. Degoricija, E. Nham i B. Wettermark, "The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015", Expert Review of Pharmacoeconomics & Outcomes Research, vol. 18, br. 6, str. 641-646, Prosinac 2018. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:735210. [Citirano: 24.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:735210
Podaci o radu
Naslov (engleski)The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015
AutorInes Potočnjak
AutorRobert Likić
AutorVesna Degoricija
AutorEric Nham
AutorBjörn Wettermark
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Background: The consumption of psychotropic drugs (PD) is increasing worldwide with a significant variation between countries. Croatia and Sweden have similar health and pharmaceutical systems; however, Sweden is a high-income country with developed medical care, registries, and prescribing guidelines. We sought to compare the utilization of PD between Croatia and Sweden to identify areas for improvement in rational use of drugs. ----- Methods: This was a cross-sectional study using national databases to assess utilization of PD (ATC N05, N06) in Croatia and Sweden in 2014 and 2015. ----- Results: Prescribing of PD in Croatia increased from 127 DDD/TID (defined daily dose/1000 inhabitants) in 2014 to 131 DDD/TID in 2015. In Sweden, the total utilization was higher with an increase from 183 DDD/TID in 2014 to 188 DDD/TID in 2015. There were substantial differences. In Croatia, the utilization of benzodiazepine derivatives (N05BA) was 72.5 DDD/TID in 2014 and increased to 74.4 DDD/TID, in 2015. In Sweden, the utilization was only 11.2 DDD/TID for benzodiazepine derivatives in both years. ----- Conclusions: There were substantial differences in utilization of PD between Croatia and Sweden. Highlighting the problem of inappropriate benzodiazepine utilization in Croatia can help to introduce measures to change prescribing habits and improve prescribing quality.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaExpert Review of Pharmacoeconomics & Outcomes Research
Brojčani podacivol. 18, br. 6, str. 641-646
p-ISSN1473-7167
e-ISSN1744-8379
DOIhttps://doi.org/10.1080/14737167.2018.1507820
URN:NBNurn:nbn:hr:105:735210
Datum objave publikacije2018-12
URL dokumentahttps://www.tandfonline.com/doi/full/10.1080/14737167.2018.1507820
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2021-02-05 08:42:00